🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

More Than $8M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

Published 26/09/2023, 13:53
© Reuters.  More Than $8M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
KIRK
-
CXDO
-
ESNT
-
SPRO
-

Benzinga - by Lisa Levin, Benzinga Editor.

The Dow Jones closed higher by more than 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

ARS Pharmaceuticals

  • The Trade: ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Director Rajeev Shah acquired a total of 2,700,000 shares an average price of $3.03. To acquire these shares, it cost around $8.18 million.
  • What’s Happening: The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals’ New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type I), including anaphylaxis (fatal allergic reaction) for adults and children ≥30 kg.
  • What ARS Pharmaceuticals Does: ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy (previously referred to as ARS-1) for the emergency treatment of Type I allergic reactions, including anaphylaxis.
Crexendo
  • The Trade: Crexendo, Inc. (NASDAQ: CXDO) Director Anil Puri acquired a total of 5,000 shares at an average price of $2.09. To acquire these shares, it cost around $10,445.
  • What’s Happening: Crexendo posted upbeat second-quarter results.
  • What Crexendo Does: Crexendo Inc is a provider of cloud communications, UCaaS, call center, collaboration services, and other cloud business services.
Check This Out: Top 4 Tech Stocks That May Collapse This Month

Emeren Group

  • The Trade: Emeren Group Ltd (NYSE: SOL) Director Shah Capital Management acquired a total of 437,258 shares at an average price of $2.92. The insider spent $1.28 million to buy those shares.
  • What’s Happening: Emeren Group posted better-than-expected quarterly earnings.
  • What Emeren Group Does: Emeren Group Ltd is a leading global solar project developer, owner, and operator with a ~3 GW pipeline of projects and IPP assets across Europe, North America, and Asia.
Kirkland's
  • The Trade: Kirkland's, Inc. (NASDAQ: KIRK) Interim CEO Ann E Joyce acquired a total of 3,978 shares at an average price of $1.75. The insider spent around $6,962.
  • What’s Happening: Kirkland's reported weaker-than-expected second-quarter FY23 results.
  • What Kirkland's Does: Kirkland's Inc is a specialty retailer of home decor and gifts in the United States.

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.